HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francisco Javier Godoy-Navarrete Selected Research

pigment 870

11/2022Relationship between polyautoimmunity and sarcopenic obesity in rheumatoid arthritis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francisco Javier Godoy-Navarrete Research Topics

Disease

4Rheumatoid Arthritis
02/2024 - 01/2021
3Interstitial Lung Diseases (Interstitial Lung Disease)
04/2023 - 01/2021
2Inflammation (Inflammations)
04/2023 - 06/2022
1Necrosis
02/2024
1Infections
01/2024
1Sarcopenia
11/2022
1Lung Diseases (Lung Disease)
06/2022
1COVID-19
04/2022
1Diabetes Mellitus
04/2022
1Obesity
08/2021
1Overweight
08/2021
1Idiopathic Pulmonary Fibrosis
02/2021

Drug/Important Bio-Agent (IBA)

2Abatacept (Orencia)FDA Link
06/2022 - 02/2021
2Rituximab (Mabthera)FDA Link
04/2022 - 02/2021
1Certolizumab PegolFDA Link
02/2024
1Tumor Necrosis Factor InhibitorsIBA
02/2024
1Rheumatoid FactorIBA
02/2024
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2024
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2024
1Biomarkers (Surrogate Marker)IBA
04/2023
1CytokinesIBA
04/2023
1pigment 870IBA
11/2022
1ResistinIBA
11/2022
1VaccinesIBA
04/2022
1Proteins (Proteins, Gene)FDA Link
02/2021
1tocilizumab (atlizumab)FDA Link
02/2021
1Antirheumatic Agents (DMARD)IBA
01/2021

Therapy/Procedure

1Therapeutics
01/2024
1Duration of Therapy
08/2021